Scientists at the University of North Carolina at Chapel Hill have discovered three genes crucial to the survival of cells, they reported in the April 23 issue of the journal Molecular Cell. The genes select cellular proteins for the disposal and eventual recycling of their components.
Clinical trials are now underway at the University of North Carolina at Chapel Hill on a promising new drug in the fight against malignant and recurrent brain tumors that have so far proved very difficult to treat.
Women with a history of sexual and physical abuse are more likely to have poor health during pregnancy and after childbirth, according to a study at the University of North Carolina at Chapel Hill.
New research at the University of North Carolina at Chapel Hill ties estrogen replacement to reducing blood pressure in older women with hypertension.
A new study at the University of North Carolina at Chapel Hill links increased levels of the hormone oxytocin to lower blood pressure among mothers who nurse their babies. The findings help explain why many breast-feeding mothers report feeling mellow and relaxed after nursing.
A study by researchers at the University of North Carolina at Chapel Hill has identified molecular changes in nerve cells that may play an important role in an abnormal pain syndrome -- causalgia -- which often eludes effective treatment.
In a medical first for North Carolina, pediatric surgeons at the University of North Carolina at Chapel Hill have corrected a common chest-wall deformity called "funnel chest" by using a new, simpler operation.
In a study of life's beginnings, scientists at the University of North Carolina at Chapel Hill have moved a step closer to unraveling the biochemical mystery of embryogenesis, the process by which an egg cell transforms into an embryo.
AIDS investigators at the University of North Carolina at Chapel Hill are testing the first of a new class of drugs that attacks HIV before it enters the cell and may prove effective for patients with drug-resistant HIV.
An associate professor of social medicine and history at the University of North Carolina at Chapel Hill, has been named one of 10 international recipients of a $1 million James S. McDonnell Centennial Fellowship.
A gene therapy clinical trial for Fanconi anemia, a fatal inherited blood disease, is set to begin at the University of North Carolina at Chapel Hill.
Molecular doorways on the surface of cells may be important factors in the success or failure of human gene therapy using altered viruses, according to researchers at the University of North Carolina at Chapel Hill, who reported their study Jan. 4 in the journal Nature Medicine.
Researchers at the University of North Carolina at Chapel Hill confirmed the safety of digoxin, one of the oldest and most frequently prescribed medicines and the most common digitalis drug for heart failure, in the December 7-21 issue of the Archives of Internal Medicine.
Researchers at the University of North Carolina at Chapel Hill are applying the same mathematics used for measuring the earth's seismic activity to finding early signs of heart trouble.
University of North Carolina researchers have used an antibiotic like an on-off switch to externally regulate a gene carried by a defective virus and implanted in the brain. The report in the Dec. 2 journal Gene Therapy, suggests that gene-transfer technology using a recombinant defective virus in laboratory rats may prove feasible for gene therapy in human brain disorders such as Parkinson's disease and epilepsy.
More than half of women with a very severe form of premenstrual syndrome are likely to have histories of physical or sexual abuse during childhood or adolescence, according to research by scientists at the University of North Carolina at Chapel Hill.
Scientists at the University of North Carolina at Chapel Hill have invented a solid-state metal sensor -- roughly the thickness of three human hairs -- that can measure the acidity (pH) of chemical solutions,including body fluids. A report describing the invention is published in the December issue of Analytical Chemistry.
In a scientific first, researchers at the University of North Carolina at Chapel Hill have reduced the severity of arthritis by turning off a molecular switch, a gene called NF-kappa B.
A study by the University of North Carolina at Chapel Hill confirms the presence of mutated, drug-resistant human immunodeficiency virus in the semen of men taking antiviral medications for HIV infection.
Scientists at the University of North Carolina at Chapel Hill have found that a gene discovered earlier in the decade has paradoxical properties -- it helps bring about tumor cell death yet is also necessary for their growth.
Peoplw withheart failure are less likely to experience a worsening of their condition if they are treated with three drugs, suggests a study co-authored by researchers from the University of North Carolina at Chapel Hill.
In a scientific first, researchers at the University of North Carolina at Chapel Hill have demonstrated that allergy increases susceptibility to otitis media, the most common, recurrent ear infection in young children.
Some of the nation's leading medical reporters will speak at the University of North Carolina at Chapel Hill Nov. 14-15 in a symposium for working medical journalists and medical communications specialists.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right